Why the study?
Does the 125I fibrinogen test accurately detect deep vein thrombosis in high-risk patients?
Does the 125I fibrinogen test accurately detect deep vein thrombosis in high-risk patients?
The 125I fibrinogen test is a simple, accurate (92%), and portable method for detecting deep vein thrombosis in the legs, though it is limited in detecting proximal thrombi.
Supports 125I fibrinogen test for DVT detection in high-risk patients; leaves open larger prospective validation against modern standards.
A simplified technique for detecting phlebothrombosis of the legs is using radioiodinated fibrinogen. In 88 patients, the accuracy of the test was 92%, as determined by concurrent phlebography. The test was also applied in 784 patients in various high risk groups, wherein the incidence of phlebothrombosis was as follows: 469 elective surgical patients, 27.8%; 50 patients with hip fractures, 54%; 42 patients undergoing prostatectomy, 23.8%; 100 obstetric patients, 3%; 92 women undergoing major gynecological surgery, 18.8%; and 31 patients with proven myocardial infarction, 19%. The method was also useful in 82 patients thought to have established phlebothrombosis by clinical criteria. Disadvantages of the test include its inability to detect phlebothrombosis in the upper femoral and iliac regions, the possible risk of serum hepatitis (no cases seen in over 800 patients studied), and the number of personnel required if a large number of patients are to be screened. Its advantages are simplicity, accuracy, portability, and lack of trauma.
No takes yet. Share an insight, caveat, or question.
Vijay V. Kakkar (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: